Western Wealth Management’s GSK GSK Stock Holding History

Western Wealth Management’s Portfolio GSK Stock Details GSK Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	–	Sell	-1,658	Closed	-$3.42M	–	1028
2026 Q1	$3.42M	Buy	+1,658	New	+$89.8K	0.13%	163
2022 Q3	–	Sell	-6,078	Closed	-$330K	–	825
2022 Q2	$330K	Buy	6,078 +4	+0.1%	+$221	0.02%	583
2022 Q1	$331K	Buy	6,074 +2,233	+58%	+$121K	0.02%	643
2021 Q4	$211K	Buy	+3,841	New	+$200K	0.02%	571
2021 Q2	$200K	Buy	+3,970	New	+$191K	0.02%	606

Other funds holding GSK

Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return

Dodge & Cox San Francisco, California $191B AUM 17.5% 1-Year Est. Return

Fisher Asset Management Camas, Washington $336B AUM 34.66% 1-Year Est. Return

Primecap Management Pasadena, California $169B AUM 114.72% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return

JEST

JTC Employer Solutions Trustee St Helier, Jersey $1.25B AUM 41.83% 1-Year Est. Return

Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

Royal Bank of Canada Toronto, Ontario, Canada $672B AUM 33.48% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return

Acadian Asset Management Boston, Massachusetts $84.2B AUM 55.88% 1-Year Est. Return

Western Wealth Management's GSK Position: Q2 2026 in Review

Western Wealth Management sold out of GSK (GSK) in Q2 2026, closing a stake of 1,658 shares — an estimated $3.42M sold.

Western Wealth Management first reported a position in GSK in Q2 2021 and held it in 5 quarters. The position peaked at $3.42M in Q1 2026. 1,037 funds tracked by Wall St. Rank hold GSK as of Q2 2026.

Western Wealth Management reported no remaining GSK position as of Q2 2026 after selling out during the quarter.
Western Wealth Management sold 1,658 GSK shares in Q2 2026, an estimated $3.42M.
Western Wealth Management first reported a position in GSK in Q2 2021 and held it in 5 quarters.
Western Wealth Management's GSK position peaked at $3.42M in Q1 2026.
1,037 funds tracked by Wall St. Rank held GSK as of Q2 2026.

Based on Western Wealth Management's 13F filing for Q2 2026, filed 14 Aug 2026.